Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.2B | 10.5B | 9.8B | 10.4B |
Cost of revenue | 5.8B | 6.1B | 5.5B | 5.7B |
Gross profit | 4.4B | 4.4B | 4.3B | 4.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.0B | 2.0B | 2.0B | 2.1B |
Operating income | 1.4B | 1.4B | 1.2B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 25M | 33M | 15M | 25M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 1.5B | 1.3B | 1.5B |
Tax provision | 292M | 376M | 339M | 397M |
Net income | 1.1B | 1.1B | 979M | 1.1B |
Basic EPS | — | 23.9 | 21.5 | 25.2 |
Diluted EPS | — | 23.9 | 21.5 | 25.2 |
Basic average shares | — | 45.5M | 45.6M | 45.5M |
Diluted average shares | — | 45.5M | 45.6M | 45.5M |
EBITDA | 1.6B | 1.7B | 1.6B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |